Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
OSRX, Inc. Responds to Jury Verdict in Trademark Infringement Case https://t.co/k4BrS74aZn https://t.co/OkBC4GgmxX
$LIFW (+38.5% pre) LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement - SI https://t.co/jSuQQwxLn3
$HROW Harrow announces favorable jury verdict in ImprimisRx, LLC v. OSRX, Inc.; Receives $34.9 mln award for punitive and actual damages (42.44 million https://t.co/wvbhb7Wsqw
Harrow Health's subsidiary, ImprimisRx, has been awarded $34.9 million by a jury in the case of ImprimisRx, LLC v. OSRX, Inc. The unanimous verdict includes both punitive and actual damages. This legal victory is significant for Harrow, as it reinforces the company's position in the pharmaceutical sector. In a related development, OSRX, Inc. has responded to the jury's verdict regarding trademark infringement, indicating ongoing legal implications for both parties involved.
